申博sunbet

Uni-Bio Science Group

Uni-Bio Science Group (Stock Code: 0690), established in 2001, is a leading Chinese biopharmaceutical healthcare company focusing on the four strategic areas of bio-innovative drugs, high-value generic drugs, medical cosmetology, and CMO, integrating R&D, production and sales.

Uni-Bio Science is committed to improving the quality of life of patients through innovative therapies and is built upon the vision of addressing the pressing needs in the provision of high-quality Chinese healthcare solutions. China’s well-documented chronic diseases, ageing population and growing population places great strain on our healthcare systems, however Uni-Bio Science has built broad capability to address this challenge both in the breadth of its product portfolio and experienced commercial function, and has achieved several major milestones.

See More
MILESTONES

Uni-Bio Science Group (Stock Code: 0690), established in 2001, is a leading Chinese biopharmaceutical healthcare company focusing on the four strategic areas of bio-innovative drugs, high-value generic drugs, medical cosmetology, and CMO, integrating R&D, production and sales.

Uni-Bio Science is built upon the vision of addressing the pressing needs in the provision of high-quality Chinese healthcare solutions. China’s well-documented chronic diseases, ageing population and growing population places great strain on our healthcare systems, however Uni-Bio Science has built broad capability to address this challenge both in the breadth of its product portfolio and experienced commercial function.

Uni-Bio Science is committed to improving the quality of life of patients through innovative therapies and is built upon the vision of addressing the pressing needs in the provision of high-quality Chinese healthcare solutions. China’s well-documented chronic diseases, ageing population and growing population places great strain on our healthcare systems, however Uni-Bio Science has built broad capability to address this challenge both in the breadth of its product portfolio and experienced commercial function, and has achieved several major milestones.

We have proactively bolstered our operational capabilities to continue the strong momentum we have achieved: establishing new Medical and Market Access departments; and increasing both our field activities and share of voice.

Uni-Bio Science has established a strong track record in its approach to bolstering its product portfolio through strategic partnerships and in-licensing agreements. We have recently formed a strategic alliance with Heungkong Group, a top 50 PRC private enterprise on exploring promotion opportunities for Uni-Bio product in their healthcare networks as well as other initiatives. The alliance reassured the broad commercial and development expertise that we have nurtured within our organisation, combined with our commitment to operating ethically and responsibly, positions us as the partner of choice of many reputable healthcare companies and beyond. Our innovative business model ensures we will remain competitive and is enabling us to build a portfolio of world-class treatments and healthcare solutions for patients throughout China.

We have invested, and continue to invest, in ensuring we operate supply chains with utmost security and accountability, especially in good compliance to the latest distribution policy of PRC. Our manufacturing facilities throughout China have all been fitted with state-of the-art equipment and are cGMP approved, establishing the Group as the provider of choice in the provision of high-quality products.

With the strong foundation and good track records in the focused therapeutic domain, Uni-Bio will continue to strive to become a leader for chronic diseases management and provide innovative healthcare products and solution to the Nation.

The whole Uni-Bio family share a common goal: to become a leading provider of professional, affordable, high quality healthcare product in China, and eventually the world, and to lead the advancement of the industry. Step forward together with the company, Uni-Biologists also share the fruits of innovation and common glory for personal development.

• Uni-Bio earns customers’ respect through providing best healthcare solution with innovative concept.

• Uni-Bio attracts talents and earns their respect through providing valuable career development opportunities and warmly humanistic care.

• Uni-Bio earns peers’ respect through operational excellence and becoming a leading expert in the biopharmaceutical industry.

• Uni-Bio earns society’s respect through making products with craftsman’s spirit and leading advancement of the industry.

Follow our promise “Leading genuine innovation”, through innovative biological technology, we provide effective solutions to doctors and patients in endocrinology with friendly price. Uni-Bio offers not only “curing” but also “caring”

• “Innovation” represents innovative technology and yearning for new high-technology.

• “Genuine” represents our continuous care to patients, best solution to diseases with friendly price.

Our efforts to succeed as a leading healthcare company focus on the delivery of truly innovative, high-quality solutions to address the pressing healthcare problems faced by patients in China.

• Caring -- We care patients and take their health as our responsibility.

• Responsible -- We are take responsibility and accountability of our actions and results.

• Leading -- We lead in the professional domain with technology and innovation.

• Focused -- We have a focused attitude to fulfil our duty in a high quality and timely manner.